About Envian Life Sciences Private Limited
Data last updated:
Envian Life Sciences Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 19 December 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74900DL2015PTC288674. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Varati Chakraborty and Tama Chakraborty.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at D – 5 Pvt No 1 T/Floor New Office No 301 Lalawadh Complex Laxmi Nagar, Delhi, India – 110092.
As per the financials filed for FY 2019, the company reported a revenue of ₹2.02 Cr, a growth of 5% compared to the previous year. For the same year it recorded a net profit of ₹4.37 Lakh (net margin 2.2%) and EBITDA of ₹17.09 Lakh (EBITDA margin 8.5%). Revenue has grown at a compounded annual rate (CAGR) of 123% over three years.
The company has about 20 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹1.75 Cr and satisfied charges of ₹1.85 Cr on record. Court records list 3 cases involving the company, including 3 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website envian.co.in.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressD – 5 Pvt No 1 T/Floor New Office No 301 Lalawadh Complex Laxmi Nagar, Delhi, India – 110092
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Envian Life Sciences Private Limited
The main business activity of Envian Life Sciences is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Envian Life Sciences Private Limited FY 2019 filings available
Envian Life Sciences Private Limited reported revenue of ₹2.02 Cr (up 5% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR) of Envian Life Sciences Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 123% over three years, including 5% growth in the latest year. EBITDA rose 179% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Envian Life Sciences Private Limited
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ₹2.02 Cr | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | ₹17.09 Lakh | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹4.37 Lakh | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Envian Life Sciences Private Limited
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 8.5% | •••• | •••• | •••• |
| Net Profit Margin | 2.2% | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Envian Life Sciences are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Envian Life Sciences Private Limited
Envian Life Sciences has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Varati Chakraborty | Director | 03 Mar 2016 | 10 Years 7 Months | Current |
| Tama Chakraborty | Director | 19 Dec 2015 | 10 Years 10 Months | Current |
Peer Comparison of Envian Life Sciences Private Limited
Envian Life Sciences Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Baba Brothers Healthcare Private Limited | ₹2.02 Cr (FY 2025) | •••• | •••• | 13.0% | •••• | Gurugram, Haryana, India |
| S G I Pharmacuticals Limited | ₹2.02 Cr (FY 2023) | •••• | •••• | 798.0% | •••• | New Delhi, Delhi, India |
| Gypsopiea Pharmaceutical Private Limited | ₹2.02 Cr (FY 2025) | •••• | •••• | -9.0% | •••• | Pune, Maharashtra, India |
| Vogue Pharmaceuticals Private Limited | ₹2.02 Cr (FY 2025) | •••• | •••• | -5.0% | •••• | New Delhi, Delhi, India |
| Acmesujan Pharmachem Private Limited | ₹2.02 Cr (FY 2025) | •••• | •••• | 452.0% | •••• | Jalgaon, Maharashtra, India |
| Envian Life Sciences Private Limited this company | ₹2.02 Cr (FY 2019) | •••• | •••• | 5.0% | •••• | Delhi, India |
| Oncomed Pharmaceuticals India Private Limited | ₹2.02 Cr (FY 2025) | •••• | •••• | -54.0% | •••• | Patna, Bihar, India |
| Swarnamayee Healthcare Private Limited | ₹2.02 Cr (FY 2025) | •••• | •••• | 22.0% | •••• | Bhubaneswar, Odisha, India |
| One Life Care Private Limited | ₹2.01 Cr (FY 2025) | •••• | •••• | -3.0% | •••• | Surat, Gujarat, India |
| Akshat Pharma Private Limited | ₹2.01 Cr (FY 2025) | •••• | •••• | -1.0% | •••• | New Delhi, Delhi, India |
| Zoetic Formulations Private Limited | ₹2.01 Cr (FY 2025) | •••• | •••• | -5.0% | •••• | Chennai, Tamil Nadu, India |
Peers are the five companies nearest above and the five nearest below Envian Life Sciences by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Envian Life Sciences Private Limited
Envian Life Sciences Private Limited is audited by CHAKRABARTI & ASSOCIATES for the financial year 2018.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| CHAKRABARTI & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Envian Life Sciences Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Envian Life Sciences Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Jan 2020 | Others | ₹1.25 Cr | Open |
| 13 Jan 2020 | Others | ₹50 Lakh | Open |
| 29 May 2019 | Karnataka Bank Ltd. | ₹65 Lakh | Satisfied |
| 28 Mar 2019 | Karnataka Bank Ltd. | ₹75 Lakh | Satisfied |
| 02 Apr 2016 | Karnataka Bank Ltd. | ₹45 Lakh | Satisfied |
Total charge records: 5 View all charges
Legal Cases of Envian Life Sciences Private Limited
Envian Life Sciences Private Limited has 3 court cases on record: 3 filed against it. All cases are disposed. Status as checked between 03 Oct 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 3 | 0 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, North Twenty Four Parganas, West Bengal | Criminal complaint | Filed against the company by HDFC Bank Limited | Disposed |
| District court, Panchkula, Haryana | Civil suit | Filed against the company by an individual | Disposed |
| District court, Panchkula, Haryana | Civil suit | Filed against the company by an individual | Disposed |
Full case history
All 3 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Envian Life Sciences Private Limited
Envian Life Sciences Private Limited has a workforce of 20 employees as of Apr 06, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Envian Life Sciences Private Limited
Envian Life Sciences Private Limited has 4 board changes on record since 2015: 3 appointments and 1 cessation. The latest: Suman Dutta ceased to be Director on 03 Mar 2016.
4 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Envian Life Sciences Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Envian Life Sciences Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Envian Life Sciences Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Envian Life Sciences Private Limited
Envian Life Sciences has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Envian Life Sciences Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Envian Life Sciences Private Limited
Envian Life Sciences is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 19 December 2015 (11+ years old) and is registered under CIN U74900DL2015PTC288674.
Envian Life Sciences reported revenue of ₹2.02 Cr for FY 2019 (up 5% YoY).
Envian Life Sciences has 2 current directors:
- Varati Chakraborty - Director
- Tama Chakraborty - Director
Envian Life Sciences reported a net profit of ₹4.37 Lakh (net margin 2.2%) and EBITDA of ₹17.09 Lakh (EBITDA margin 8.5%) for FY 2019, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Envian Life Sciences is 123% over three years. In the latest year (FY 2019) revenue rose 5%. CAGR is the steady yearly rate that links the first and the last year.
No. Envian Life Sciences has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Envian Life Sciences is U74900DL2015PTC288674. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Envian Life Sciences has 3 court cases on record: 3 filed against it.
Envian Life Sciences was incorporated on 19 December 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Envian Life Sciences by revenue are Baba Brothers Healthcare Private Limited, S G I Pharmacuticals Limited, Gypsopiea Pharmaceutical Private Limited, Vogue Pharmaceuticals Private Limited, Acmesujan Pharmachem Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Suman Dutta ceased to be Director on 03 Mar 2016. Varati Chakraborty was appointed as Director on 03 Mar 2016. Suman Dutta was appointed as Director on 19 Dec 2015. Envian Life Sciences has 4 board changes on record in total.